About Venclose
Venclose is a Healthcare company based in San Jose (United States) founded in 2014 by Brady Esch, and was acquired by Becton Dickinson in December 2021. Radiofrequency ablation system for treating venous reflux disease. Venclose has raised $27.1 million across 2 funding rounds from investors including BD and Ally Bridge Group. Its chief executive, as recorded, is Brady Esch. Venclose offers products and services including Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter. Its focus areas include Life Sciences, Surgical Instruments and Cutting and Ablating. Its legal entity is Becton, Dickinson and Company. Its competitors include Monteris, Symmetry Surgical and Misonix; 1 of its 3 listed competitors has raised funding.
Company details
Venclose has developed a Radiofrequency (RF) ablation system for the treatment of venous reflux disease. The Venclose device consists fo two heating lengths and a catheter. The features are the instrument has markings, curved tip, minimizes invasiveness, shows real-time procedure data etc.
- Headquarters San Jose, United States
- Founders Brady Esch
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website venclose.com
- Social LinkedIn
- Acquired by Becton Dickinson (Dec 2021)
- Legal Name Becton, Dickinson And Company
- Total Equity Funding$27.1M (USD)
in 2 rounds
- Latest Funding Round$27.1M (USD), Series C
Nov 2019
- InvestorsBD
& 1 more
- Acquired byBecton Dickinson
(Dec 2021)
Products & Services of Venclose
Venclose offers a comprehensive portfolio of products and services, including Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter.
System for endovascular coagulation of blood vessels in venous reflux.
Device for treating superficial vein reflux with radiofrequency.
Catheter for managing perforator and tributary vein reflux.
Funding Insights of Venclose
Venclose has successfully raised a total of $27.1M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $27.1 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.1M
- Total Rounds 2
- Last Round Series C — $27.1M
- Investors Count 1
All 2 funding rounds of Venclose with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2019 | $27.1M | Series C | – | Ally Bridge Group | – |
| Jul 2018 | Series B | – | – | – |
2 investors in total: 2 institutional.
Investors in Venclose
Venclose has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BD and Ally Bridge Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
BD is recognized for providing innovative medical technology solutions. | 1897 | bd.com | Franklin Lakes, United States |
Investor details for Venclose
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Venclose
23 people are tracked at Venclose (9 in leadership, 2 in board & advisors, 12 in team).
| Name | Role | Group |
|---|---|---|
Brady Esch | Founder & CEO | Leadership |
Jason Turner | COO | Leadership |
Peter Osborne | CFO & Board Member | Leadership |
Mike Mirizzi | VP, Research & Development | Leadership |
Jeffrey G. Carr | Chief Medical Officer | Leadership |
Rachel M. | Director of Operations | Leadership |
Dieter Bielang | VP, Sales Europe & Middle East | Leadership |
Angela Farmer | Director of Marketing | Leadership |
DJ (Lyman)Brainard, BSN, RN | Director of Clinical Education & Training | Leadership |
Gregory Vislocky | Board Member | Board & advisors |
Charles Chon | Board Member | Board & advisors |
Kristen Haeck | Regional Sales Manager | Team |
Charles Kennedy | Territory Sales Manager | Team |
Marc Overschmidt | Territory Sales Manager | Team |
Donald Hamilton | Territory Manager | Team |
Craig Kelican | Territory Sales Manager | Team |
Marty Munn | Territory Sales Manager | Team |
Scott Smith | Territory Sales Manager | Team |
Justin Spadaro | Field Sales Trainer Territory Manager | Team |
Greg Alford | Territory Sales Manager | Team |
3 more people are available in the full profile.
Complete people profiles for Venclose
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Venclose
4 dated milestones of Venclose across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Venclose is founded.
- Funding First funding round.
- Funding Latest funding round, Series C, of $27.1M.
- Exit Acquired by Becton Dickinson.
Competitors of Venclose
Venclose has 3 listed competitors in our database, 1 of them funded. They include Monteris, Symmetry Surgical and Misonix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| monteris.com | 1999 | Plymouth, United States | $199.38M | 100 | MRI-guided laser ablation tools for neurosurgery are developed. | |
| symmetrysurgical.com | 1976 | Nashville, United States | 203 | Surgical instruments, sterilization solutions and electrosurgical products | ||
| misonix.com | 1959 | Farmingdale, United States | 1,013 | Ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery |
Detailed competitors of Venclose
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Venclose (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Venclose
Complete news archive for Venclose
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venclose
Venclose was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Venclose is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Brady Esch is the CEO of Venclose, as recorded in our data. They have also founded this company.
Venclose is a funded company, having raised a total of $27.1M across 2 funding rounds to date.
Venclose has developed a Radiofrequency (RF) ablation system for the treatment of venous reflux disease. The Venclose device consists fo two heating lengths and a catheter. The features are the instrument has markings, curved tip, minimizes invasiveness, shows real-time procedure data etc.
Venclose's top competitors include Monteris, Misonix and Symmetry Surgical.
Venclose offers Venclose RF Ablation System, Venclose RF Ablation Catheter, and Venclose Maven Perforator Catheter.
Venclose has 2 investors. Key investors include BD, and Ally Bridge Group.
Venclose operates through Becton, Dickinson And Company.
Yes. Venclose was acquired by Becton Dickinson in December 2021.